Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Organovo Holdings (NQ: ONVO ) 0.5580 -0.0020 (-0.36%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Organovo Holdings < Previous 1 2 3 Next > Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July July 18, 2024 Via Benzinga Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis July 16, 2024 From Organovo, Inc. Via GlobeNewswire ONVO Stock Earnings: Organovo Holdings Beats EPS, Misses Revenue for Q4 2024 June 03, 2024 ONVO stock results show that Organovo Holdings beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024. Via InvestorPlace Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease May 21, 2024 From Organovo, Inc. Via GlobeNewswire Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) May 14, 2024 Renowned gastrointestinal diseases conference to held in Washington, D.C. May 18-21, 2024 From Organovo, Inc. Via GlobeNewswire Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket May 09, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday May 09, 2024 Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday! Via InvestorPlace Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering May 08, 2024 From Organovo, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 16, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session April 15, 2024 Via Benzinga Why Organovo Stock Is Up Today April 15, 2024 Organovo released the complete details of its 16-week, randomized, placebo-controlled, multi-center Phase 2 study of the non-steroidal, non-bile acid FXR agonist FXR314 for the treatment of metabolic... Via Benzinga Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 15, 2024 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic... Via Benzinga Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings April 15, 2024 U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&P 500 also... Via Benzinga Topics Stocks Exposures US Equities Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo April 15, 2024 From Organovo, Inc. Via GlobeNewswire Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket April 15, 2024 Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session February 12, 2024 Via Benzinga Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress January 25, 2024 From Organovo, Inc. Via GlobeNewswire Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress January 09, 2024 From Organovo, Inc. Via GlobeNewswire Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results December 06, 2023 From Organovo, Inc. Via GlobeNewswire CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan November 13, 2023 From Organovo, Inc. Via GlobeNewswire Organovo Highlights FXR314 Combination Therapy Potential and Plan November 08, 2023 From Organovo, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session November 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session November 03, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 24, 2023 Via Benzinga Why Logitech International Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket October 24, 2023 Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares surged 91.2% to $0.2180 in pre-market trading after falling 10% on Monday. Via Benzinga Organovo to Participate in the H.C. Wainwright Global Investment Conference September 08, 2023 From Organovo, Inc. Via GlobeNewswire Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data August 23, 2023 From Organovo, Inc. Via GlobeNewswire Organovo Announces FXR Program March 21, 2023 Lead Molecule Poised for Phase 2 in IBD From Organovo, Inc. Via GlobeNewswire Cathie Wood Bulks Up On Shopify Amid Stock's 18% Post-Earnings Drop, Sells This Major Holding Up 30% This Week February 18, 2023 Cathie Wood’s Ark Invest reversed its stance on Canadian e-commerce retailer Shopify, Inc. (NYSE: SHOP) and began bulking up on the stock this week. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 15, 2023 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.